Acceliant to Participate in BioPharma Asia Convention 2013, Singapore
Acceliant, a global technology provider of innovative clinical solutions, is set to participate in BioPharma Asia Convention to be held in Singapore from March 18-21, 2013. It will showcase its comprehensive solution that provides an efficient way of managing clinical trials and data with an integrated trial builder, EDC platform and e-PRO.
Bangalore, India, February 22, 2013 --(PR.com)-- Acceliant invites all attendees to visit booth # D24 to find out more about the eClinical suite of products and discuss opportunities for collaboration in the space of clinical trial and data management.
Speaking on the participation, Ven Thangaraj, Acceliant CTO, said, "The Convention is one of the strategic events that present an opportunity to interact and exchange ideas with industry stakeholders and key decision makers across the Asian biopharmaceutical sector. We hope to leverage our interactions to make a positive impact on the biopharmaceutical fraternity through product innovations. We will showcase our eClinical Suite of products with a focus on clinical data management using mobile devices, keeping in mind the growing need of sponsors, who continue to look for technologies that streamline and accelerate the clinical trials."
"BioPharma Asia Convention is an excellent platform to showcase our eClinical suite of products that deliver end-to-end clinical trial data management solutions. Acceliant has partnered with some of the renowned pharmaceutical and CROs in the US over a decade providing efficient CDM solution. Demonstrating the importance of capturing and reporting precise data for effective medical monitoring during clinical trials will be our focus. We look forward to interact and exchange knowledge on helping us raise the standards of healthcare worldwide," added Santhosh S. Nagaraj, Acceliant Sales Head.
Acceliant eClinical Suite
Acceliant eClinical Suite is competitive in meeting the challenges of today’s dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 12-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.
Speaking on the participation, Ven Thangaraj, Acceliant CTO, said, "The Convention is one of the strategic events that present an opportunity to interact and exchange ideas with industry stakeholders and key decision makers across the Asian biopharmaceutical sector. We hope to leverage our interactions to make a positive impact on the biopharmaceutical fraternity through product innovations. We will showcase our eClinical Suite of products with a focus on clinical data management using mobile devices, keeping in mind the growing need of sponsors, who continue to look for technologies that streamline and accelerate the clinical trials."
"BioPharma Asia Convention is an excellent platform to showcase our eClinical suite of products that deliver end-to-end clinical trial data management solutions. Acceliant has partnered with some of the renowned pharmaceutical and CROs in the US over a decade providing efficient CDM solution. Demonstrating the importance of capturing and reporting precise data for effective medical monitoring during clinical trials will be our focus. We look forward to interact and exchange knowledge on helping us raise the standards of healthcare worldwide," added Santhosh S. Nagaraj, Acceliant Sales Head.
Acceliant eClinical Suite
Acceliant eClinical Suite is competitive in meeting the challenges of today’s dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 12-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.
Contact
Trianz Consulting Inc
Prashant Bhavaraju
1-408-387-5800
www.trianz.com
Prashant Bhavaraju
1-408-387-5800
www.trianz.com
Contact
Categories